Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-29
1998-02-10
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514313, 514314, 514913, A61K 3147
Patent
active
057169667
ABSTRACT:
The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and
REFERENCES:
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4029792 (1977-06-01), Danielewicz et al.
patent: 4036976 (1977-07-01), Neumann
patent: 4217356 (1980-08-01), Neumann
patent: 4398028 (1983-08-01), Neumann
patent: 5021416 (1991-06-01), Gluchowski
patent: 5091528 (1992-02-01), Gluchowski
patent: 5180721 (1993-01-01), Burke
patent: 5231096 (1993-07-01), Gluchowski et al.
patent: 5281591 (1994-01-01), Burke
Cambridge, D., "UK-14,304, A Potent and Selective .alpha..sub.2 -Agonist for the Characterization of .alpha.-Adrenoceptor Subtypes", European Journal of Pharmacology, vol. 72, pp. 413-415 (no month identified 1981).
Chapleo, C.B., J.C. Doxey, P.L. Myers, M. Myers, C.F.C. Smith and M.R. Stillings, "Effect of 1,4-Dioxanyl Substitution on the Adrenergic Activity of some Standard .alpha.-Adrenoreceptor Agents", European Journal of Medicinal Chemistry, vol. 24, pp. 619-622 (no month identified 1989).
Chapleo, C.B., R.C.M. Butler, D.C. England, P.L. Myers, A.G. Roach, C.F.C. Smith, M.R. Stillings and I.F. Tulloch, "Heteroaromatic Analogues of the .alpha..sub.2 -Adrenoreceptor Partial Agonist Clondine", J. Med. Chem., vol. 32, pp. 1627-1630 (no month identified 1989).
Clare, K.A., M.C. Scrutton and N.T. Thompson, "Effects of .alpha..sub.2 -Adrenoreceptor Agonists and of Related Compounds on Aggregation of, and on Adenylate Cyclose Activity in, Human Platelets", Br. J. Pharmacl, vol. 82, pp. 467-476 (no month identified 1984).
Megens, A.A.H.P., J.E. Leysen, F.H.L. Awouters and C.J.E. Niemegeers, "Ruther Validation of In Vivo and In Vitro Pharmacological Procedures for Assessing the .alpha..sub.2/ .alpha..sub.1 -Selectivity of Test Compounds: (2) .alpha.-Adrenoceptor Agonists", European Journal of Pharmacology, vol. 129, pp. 57-64 (no month identified 1986).
Timmermans, P.B.M.W.M. and P.A. van Zwieten, ".alpha..sub.2 -Adrenoceptor Agonists and Antagonists", Drugs of the Future, vol., 9, No. 1, pp. 41-55 (Jan., 1984).
Timmermans, P.B.M.W.M.A.T. Chiu and M.J.M.C. Thoolen, "12,1 .alpha..sub.2 -Adrenergic Receptors", Comprehensive Medicinal Chemistry, vol. 3, Membranes & Receptors, pp. 133-185 (no month identified 1990).
Timmermans, P.B.M.W.M.A. de Jonge, M.J.M.C. Thoolen, B. Wilffert, H. Batink and P.A. van Zwieten, "Quantitative Relationships between .alpha..sub.2 -Adrenergic Activity and Binding Affinity of .alpha..sub.2 -Adrenoceptor Agonists and Antagonists", J. Med. Chem., vol. 27, pp. 495-503 (no month identified 1984).
Van Meel, J.C.A., A. de Jonge, P.B.M.W.M. Timmermans and P.A. van Zwieten, "Selectivity of Some Alpha Adrenoceptor Agonists for Peripheral Alpha-1 and Alpha-2 Adrenoceptors in the Normotensive Rat", The Journal of Pharmacology and Experimental Therapeutics, vol. 219, pp. 760-767 (no month identified 1981).
Zinchenko, T.M., "Investigation of Autoallergenic Action of Dibutyl and Dioctyl Phthalates", Gig. Sanit., vol. 1, pp. 79-80, (1984).
U.S. application No. 08/496,704, Cupps et al., filed Jun. 29, 1995.
U.S. application No. 08/496,706, Cupps et al., filed Jun. 29, 1995.
U.S. application No. 08/496,707, Maurer, filed Jun. 29, 1995.
Bogdan Sophie Eva
Cupps Thomas Lee
Fay Zohreh
Graff Milton B.
Hake Richard A.
The Procter & Gamble & Company
LandOfFree
7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2077619